Murine Cutaneous Mastocytosis and Epidermal Melanocytosis Induced by Keratinocyte Expression of Transgenic Stem Cell Factor
Open Access
- 18 May 1998
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 187 (10) , 1565-1573
- https://doi.org/10.1084/jem.187.10.1565
Abstract
The growth and differentiation of mast cells and melanocytes require stem cell factor (SCF), the ligand for the kit receptor tyrosine kinase. SCF may exist as a membrane-bound or soluble molecule. Abnormalities of the SCF-kit signaling pathway, with increased local concentrations of soluble SCF, have been implicated in the pathogenesis of the human disease cutaneous mastocytosis, but have not yet been shown to play a causal role. To investigate both the potential of SCF to cause mastocytosis and its role in epidermal melanocyte homeostasis, we targeted the expression of SCF to epidermal keratinocytes in mice with two different transgenes controlled by the human keratin 14 promoter. The transgenes contained cDNAs that either produced SCF, which can exist in both membrane-bound and soluble forms, or SCF, which remains essentially membrane bound. Murine epidermal keratinocyte expression of membrane-bound/ soluble SCF reproduced the phenotype of human cutaneous mastocytosis, with dermal mast cell infiltrates and epidermal hyperpigmentation, and caused the maintenance of a population of melanocytes in the interadnexal epidermis, an area where melanocytes and melanin are found in human skin but where they are not typically found in murine skin. Expression of membrane-bound SCF alone resulted in epidermal melanocytosis and melanin production, but did not by itself cause mastocytosis. We conclude, first, that a phenotype matching that of human mastocytosis can be produced in mice by keratinocyte overproduction of soluble SCF, suggesting a potential cause of this disease. Second, we conclude that keratinocyte expression of membrane-bound SCF results in the postnatal maintenance of epidermal melanocytes in mice. Since the resulting animals have skin that more closely approximates human skin than do normal mice, their study may be more relevant to human melanocyte biology than the study of skin of normal mice.Keywords
This publication has 54 references indexed in Scilit:
- Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo.The Journal of Experimental Medicine, 1996
- Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patientsJournal of the American Academy of Dermatology, 1995
- Effects of Monoclonal Anti-c-Kit Antibody (ACK2) on Melanocytes in Newborn MiceJournal of Investigative Dermatology, 1995
- Expression of stem cell factor in cutaneous mastocytosisBritish Journal of Dermatology, 1995
- The mast cell and mast cell diseaseJournal of the American Academy of Dermatology, 1995
- Human Dermal Endothelial Cells Express Membrane-Associated Mast Cell Growth FactorJournal of Investigative Dermatology, 1995
- Is Mastocytosis a Mast Cell Neoplasia or a Reactive Hyperplasia? Clues from the Study of Mast Cell Growth FactorAnnals of Medicine, 1994
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.Journal of Clinical Investigation, 1993
- The kit ligand: A cell surface molecule altered in steel mutant fibroblastsCell, 1990
- ALCIAN BLUE—A CONSUMERS' GUIDEJournal of Histochemistry & Cytochemistry, 1970